Cormorant Global Healthcare Master Fund, LP

Overview

• HeadquartersBoston, United States²
• Legal formexempted limited partnership²
• Kind of organizationFund²
• LEI5493006FCXDCG8ZPDW97²
• StatusActive²
• LEI statusIssued and current²
• Registered addressP. O. Box 309, Ugland House, South Church Street, KY1-1104 George Town, Grand Cayman, Cayman Islands²
• Registered withGeneral Registry, 71235²

See how the biggest companies compare on our leaderboards

Corporate structure

Cormorant Global Healthcare Master Fund, LP sits at the top of its group. 8 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (7 companies). Each entity in the chart links to its source.

Subsidiaries and ownership

Fund manager

• Cormorant Asset Management, LP²

Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.

Timeline

1. Apr 2, 2013Founded Cormorant Global Healthcare Master Fund, LP is founded²

Stakes it holds

Cormorant Global Healthcare Master Fund, LP has told the SEC it owns more than 5% of 7 companies, latest first (Schedules 13D and 13G).

• Corbus PharmaceuticalsSC 13G Feb 5, 2024³
• Praxis Precision Medicines, Inc.SC 13G/A Jul 3, 2023⁴
• GreenLight Biosciences Holdings, PBCSC 13D Jun 8, 2023⁵
• EyePoint PharmaceuticalsSC 13G/A May 1, 2023⁶
• Biomea Fusion, Inc.SC 13D/A Apr 3, 2023⁷
• Edgewise Therapeutics, Inc.SC 13G/A Feb 14, 2022 to Feb 14, 2023⁸
• Rain Oncology Inc.SC 13G/A Feb 14, 2022 to Feb 14, 2023⁹